You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 16, 2025

Drug Price Trends for HM IBUPROFEN PM CAPLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HM IBUPROFEN PM CAPLET

Average Pharmacy Cost for HM IBUPROFEN PM CAPLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HM IBUPROFEN PM CAPLET 62011-0335-01 0.12499 EACH 2024-07-17
HM IBUPROFEN PM CAPLET 62011-0335-01 0.12529 EACH 2024-06-19
HM IBUPROFEN PM CAPLET 62011-0335-01 0.12541 EACH 2024-05-22
HM IBUPROFEN PM CAPLET 62011-0335-01 0.12565 EACH 2024-04-17
HM IBUPROFEN PM CAPLET 62011-0335-01 0.12544 EACH 2024-03-20
HM IBUPROFEN PM CAPLET 62011-0335-01 0.12221 EACH 2024-02-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for HM Ibuprofen PM Caplet

Overview of the Ibuprofen Market

The global ibuprofen market is experiencing significant growth, driven by several key factors. The market was valued at $1.43 billion in 2023 and is projected to reach $1.76 billion by 2032, growing at a CAGR of 2.44% during the forecast period[3].

Market Drivers

  • Rising Geriatric Population: The increasing age of the global population is a major driver, as older individuals are more prone to chronic diseases such as rheumatoid arthritis and osteoarthritis, which often require long-term pain management with ibuprofen[1][3].
  • Chronic Disease Prevalence: The surge in chronic diseases like arthritis, headaches, and cardiovascular diseases is boosting the demand for ibuprofen[3].
  • Healthcare Spending: Growing healthcare expenditures, particularly in regions like Asia-Pacific, are supporting the market growth. For instance, healthcare benefit costs in Asia-Pacific have been rising, contributing to increased demand for pharmaceuticals[3].
  • Over-the-Counter (OTC) Medications: The trend towards self-medication for minor ailments and the availability of OTC ibuprofen formulations are also driving market growth[1][3].

Market Segmentation

By Type

The ibuprofen market is segmented into various forms, including tablets, capsules, syrups, injections, and others. The tablet segment dominates the market due to its convenience, ease of administration, and accurate dosing. This versatility allows healthcare providers to prescribe ibuprofen tablets according to specific patient needs[1].

By Application

The market is classified into several applications, with rheumatoid arthritis and osteoarthritis being the dominant segments. This is due to the high prevalence of these conditions, particularly among the aging population, which requires sustained pain management[1].

By Distribution Channel

Hospital pharmacies dominate the distribution channel segment, as hospitals are primary healthcare facilities that handle a broad spectrum of medical conditions requiring pain management. Retail and online pharmacies also play significant roles in the distribution of ibuprofen[1].

Price Analysis for Ibuprofen PM

Current Pricing

The cost for Ibuprofen PM, which combines ibuprofen with diphenhydramine, varies depending on the pharmacy and the quantity purchased. For example, a supply of 20 tablets can cost around $12.25, with the price per unit being approximately $0.61[2].

Discounts and Assistance Programs

Consumers can use discount cards, such as the Drugs.com Discount Card, to save up to 80% on the cost of prescription and OTC medications. However, there are no specific patient assistance programs or manufacturer promotions available for Ibuprofen PM[2].

Price Projections

Global Market Trends

The global ibuprofen market is expected to grow at a CAGR of 2.44% from 2024 to 2032. This growth will likely influence the pricing of ibuprofen products, including Ibuprofen PM caplets, as demand increases and supply chains adapt to meet this demand[3].

Regional Impact

In regions like Asia-Pacific, where healthcare spending is rising, the cost of pharmaceuticals, including ibuprofen, may see adjustments. For instance, the National Pharmaceutical Pricing Authority (NPPA) in India has announced an increase in the Maximum Retail Price (MRP) of scheduled formulations, including ibuprofen, by 0.00551% starting from the fiscal year 2024-25[3].

Competitive Landscape

The ibuprofen market is competitive, with key players such as Abbott Laboratories, Solara Active Pharma Sciences, and BASF SE. These companies are adopting strategies like collaborations to develop innovative formulations. For example, BASF SE and Recipharm have collaborated to pioneer the development of more effective and easier-to-administer ibuprofen formulations[1].

Key Takeaways

  • Growing Demand: The global ibuprofen market is driven by the rising geriatric population and the increasing prevalence of chronic diseases.
  • Market Segmentation: The tablet segment and rheumatoid arthritis application segment dominate the market.
  • Pricing: Current prices for Ibuprofen PM caplets are around $12.25 for 20 tablets, with potential savings through discount cards.
  • Price Projections: The market is expected to grow, influencing pricing, with regional factors such as increased healthcare spending and regulatory changes affecting costs.
  • Competitive Landscape: Key players are innovating through collaborations to maintain market share.

FAQs

  1. What is the current market size of the global ibuprofen market?

    • The global ibuprofen market was valued at $1.43 billion in 2023[3].
  2. What is the projected growth rate of the ibuprofen market?

    • The market is expected to grow at a CAGR of 2.44% from 2024 to 2032[3].
  3. Which segment dominates the ibuprofen market by type?

    • The tablet segment dominates the market due to its convenience and accurate dosing[1].
  4. What are the primary applications of ibuprofen?

    • Rheumatoid arthritis and osteoarthritis are the dominant application segments[1].
  5. Are there any patient assistance programs available for Ibuprofen PM?

    • No specific patient assistance programs or manufacturer promotions were found for Ibuprofen PM[2].

Sources

  1. Allied Market Research - "Ibuprofen Market to Reach $213.6 Million, Globally, by 2033 at 7.9% CAGR: Allied Market Research"[1]
  2. Drugs.com - "Ibuprofen PM Prices, Coupons, Copay Cards & Patient Assistance"[2]
  3. Straits Research - "Global Ibuprofen Market Size, Top Share, CAGR of 2.44%, Report"[3]

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.